T1	Participants 865 943	A total of 1918 patients were screened for participation; 1214 were recruited.
T2	Participants 653 863	Patients aged 75 years or less were randomized in a double-blind, placebo-controlled study to test whether long-term treatment with warfarin reduces the risk of death, reinfarction, and thromboembolic morbidity
